Literature DB >> 23345405

Amyloid-β signals through tau to drive ectopic neuronal cell cycle re-entry in Alzheimer's disease.

Matthew E Seward1, Eric Swanson, Andrés Norambuena, Anja Reimann, J Nicholas Cochran, Rong Li, Erik D Roberson, George S Bloom.   

Abstract

Normally post-mitotic neurons that aberrantly re-enter the cell cycle without dividing account for a substantial fraction of the neurons that die in Alzheimer's disease (AD). We now report that this ectopic cell cycle re-entry (CCR) requires soluble amyloid-β (Aβ) and tau, the respective building blocks of the insoluble plaques and tangles that accumulate in AD brain. Exposure of cultured wild type (WT) neurons to Aβ oligomers caused CCR and activation of the non-receptor tyrosine kinase, fyn, the cAMP-regulated protein kinase A and calcium-calmodulin kinase II, which respectively phosphorylated tau on Y18, S409 and S416. In tau knockout (KO) neurons, Aβ oligomers activated all three kinases, but failed to induce CCR. Expression of WT, but not Y18F, S409A or S416A tau restored CCR in tau KO neurons. Tau-dependent CCR was also observed in vivo in an AD mouse model. CCR, a seminal step in AD pathogenesis, therefore requires signaling from Aβ through tau independently of their incorporation into plaques and tangles.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23345405      PMCID: PMC3635465          DOI: 10.1242/jcs.1125880

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  50 in total

Review 1.  Cell cycle molecules define a pathway required for neuron death in development and disease.

Authors:  Lloyd A Greene; David X Liu; Carol M Troy; Subhas C Biswas
Journal:  Biochim Biophys Acta       Date:  2006-12-13

Review 2.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

3.  Characterization of an orange acceptor fluorescent protein for sensitized spectral fluorescence resonance energy transfer microscopy using a white-light laser.

Authors:  Yuansheng Sun; Cynthia F Booker; Sangeeta Kumari; Richard N Day; Mike Davidson; Ammasi Periasamy
Journal:  J Biomed Opt       Date:  2009 Sep-Oct       Impact factor: 3.170

4.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

5.  Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease.

Authors:  Kristina R Patterson; Christine Remmers; Yifan Fu; Sarah Brooker; Nicholas M Kanaan; Laurel Vana; Sarah Ward; Juan F Reyes; Keith Philibert; Marc J Glucksman; Lester I Binder
Journal:  J Biol Chem       Date:  2011-05-06       Impact factor: 5.157

6.  Quantifying biomarkers of cognitive dysfunction and neuronal network hyperexcitability in mouse models of Alzheimer's disease: depletion of calcium-dependent proteins and inhibitory hippocampal remodeling.

Authors:  Jorge J Palop; Lennart Mucke; Erik D Roberson
Journal:  Methods Mol Biol       Date:  2011

7.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

Review 8.  Tau phosphorylation: the therapeutic challenge for neurodegenerative disease.

Authors:  Diane P Hanger; Brian H Anderton; Wendy Noble
Journal:  Trends Mol Med       Date:  2009-02-24       Impact factor: 11.951

9.  Tau protein is required for amyloid {beta}-induced impairment of hippocampal long-term potentiation.

Authors:  Olivia A Shipton; Julie R Leitz; Jenny Dworzak; Christine E J Acton; Elizabeth M Tunbridge; Franziska Denk; Hana N Dawson; Michael P Vitek; Richard Wade-Martins; Ole Paulsen; Mariana Vargas-Caballero
Journal:  J Neurosci       Date:  2011-02-02       Impact factor: 6.167

10.  A comparative study of five mouse models of Alzheimer's disease: cell cycle events reveal new insights into neurons at risk for death.

Authors:  Luming Li; Timmy Cheung; Jianmin Chen; Karl Herrup
Journal:  Int J Alzheimers Dis       Date:  2011-09-08
View more
  72 in total

1.  Disruption of the nuclear membrane by perinuclear inclusions of mutant huntingtin causes cell-cycle re-entry and striatal cell death in mouse and cell models of Huntington's disease.

Authors:  Kuan-Yu Liu; Yu-Chiau Shyu; Brett A Barbaro; Yuan-Ta Lin; Yijuang Chern; Leslie Michels Thompson; Che-Kun James Shen; J Lawrence Marsh
Journal:  Hum Mol Genet       Date:  2014-11-14       Impact factor: 6.150

2.  MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons.

Authors:  Sabrina Absalon; Dawn M Kochanek; Venkatesan Raghavan; Anna M Krichevsky
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

Review 3.  The Essential Role of Soluble Aβ Oligomers in Alzheimer's Disease.

Authors:  Zi-Xuan Wang; Lan Tan; Jinyuan Liu; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2015-04-02       Impact factor: 5.590

4.  Structure-based inhibitors of amyloid beta core suggest a common interface with tau.

Authors:  Sarah L Griner; Paul Seidler; Jeannette Bowler; Kevin A Murray; Tianxiao Peter Yang; Shruti Sahay; Michael R Sawaya; Duilio Cascio; Jose A Rodriguez; Stephan Philipp; Justyna Sosna; Charles G Glabe; Tamir Gonen; David S Eisenberg
Journal:  Elife       Date:  2019-10-15       Impact factor: 8.140

Review 5.  Critical role of mitosis in spontaneous late-onset Alzheimer's disease; from a Shugoshin 1 cohesinopathy mouse model.

Authors:  Chinthalapally V Rao; Mudassir Farooqui; Adam S Asch; Hiroshi Y Yamada
Journal:  Cell Cycle       Date:  2018-09-20       Impact factor: 4.534

6.  Cortico-hippocampal memory enhancing activity of hesperetin on scopolamine-induced amnesia in mice: role of antioxidant defense system, cholinergic neurotransmission and expression of BDNF.

Authors:  Ismail O Ishola; Abosi A Jacinta; Olufunmilayo O Adeyemi
Journal:  Metab Brain Dis       Date:  2019-04-04       Impact factor: 3.584

7.  mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer's disease.

Authors:  Andrés Norambuena; Horst Wallrabe; Lloyd McMahon; Antonia Silva; Eric Swanson; Shahzad S Khan; Daniel Baerthlein; Erin Kodis; Salvatore Oddo; James W Mandell; George S Bloom
Journal:  Alzheimers Dement       Date:  2016-09-29       Impact factor: 21.566

Review 8.  Role of Trisomy 21 Mosaicism in Sporadic and Familial Alzheimer's Disease.

Authors:  Huntington Potter; Antoneta Granic; Julbert Caneus
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

9.  Betaine suppressed Aβ generation by altering amyloid precursor protein processing.

Authors:  Xiu-Ping Liu; Xiang Qian; Yue Xie; Yan Qi; Min-Feng Peng; Bi-Cui Zhan; Zheng-Qing Lou
Journal:  Neurol Sci       Date:  2014-02-19       Impact factor: 3.307

Review 10.  Alzheimer disease: a tale of two prions.

Authors:  Justin M Nussbaum; Matthew E Seward; George S Bloom
Journal:  Prion       Date:  2012-09-10       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.